How we help you
Data-driven targetting for commercial excellence
Volv Global helps you find more of the right patients at the right time for maximum therapeutic effectiveness. This helps to accelerate product launch, maximise commercial potential, and extend the product lifecycle by expanding the market to undiagnosed and misdiagnosed patients.
Accurately segment and target market
Identify high-need populations to drive strategic focus. Improve cohort segmentation using real-world data for optimal patient triage.
Target efforts to accelerate adoption
Streamline sales by directing resources to patients most likely to respond. Pinpoint those who stand to benefit quickly and significantly from new treatments.
Extend the product lifecycle
Expand beyond diagnosed individuals to include undiagnosed or misdiagnosed patients. Intervene at the right time to maximise therapeutic effectiveness.
Enhance competitive- ness
Match evolving market needs with deep disease understanding and competitive insights. Develop more impactful awareness and commercialisation strategies.
Commercial excellence in the face of complexity
The challenge of understanding disease phenomenology
Market Segmentation
Identifying high-need populations based on diverse and incomplete datasets.
Patient Journey Complexity
Challenges in capturing the full care pathway, including missed or delayed diagnoses, delayed treatment, and the progression of untreated conditions.
Competitive Landscape
Aligning disease understanding with market needs and competitive and evolving treatment paradigms.
Data Integration
Combining clinical, economic, and patient-reported data to drive strategy.
Supporting Clinical Development
Actionable, state-of-the-art solutions for drug development
We find more patients
We find undiagnosed and misdiagnosed patients, expanding the pool of patients for clinical trial recruitment.
We detect diseases at an earlier stage
We find patients before the development of traditional symptoms, before they are given conventional therapies.
We predict patient outcomes
We enable triage of patients according to prognosis of outcomes, e.g., fast progressors, or progressors to more acute symptoms.
We stratify patient cohorts
We differentiate and cluster heterogeneous patient cohorts for more accurate definition of trial inclusion and exclusion criteria.
Leading AI/ML methodology to support
Commercial Excellence
Volv Global’s inTrigue technology
For commercial teams, inTrigue’s targetted engagement tools and comprehensive patient stratification capabilities offer a clearer picture of unmet needs across healthcare markets. By recognising hidden patient clusters and forecasting disease trajectories, organisations can tailor outreach and education strategies that resonate with specific patient segments.
With its continuous learning from new data, inTrigue ensures commercial strategies remain agile—empowering teams to refine their approach, highlight early detection benefits, and drive more precise and impactful market engagement.
Shaping the future
today
Our case studies & challenges in commercial excellence
See more
